CLINICAL EVALUTION OF BASAL-BOLUS THERAPY DELIVERED BY A 24-HOUR WEARABLE INSULIN DELIVERY DEVICE IN PATIENTS WITH TYPE 2 DIABETES
AACE ePoster Library. Zeidan T. 04/25/19; 262823; 598334
Trisha Zeidan
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
{{ help_message }}
{{filter}}